Publikationen
2012
Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz J, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien N, Živković M, Zouboulis C, Gollnick H. European Evidence-based (S3) Guidelines for the Treatment of Acne. JEADV. 2012;26:1–29. doi: 10.1111/j.1468-3083.2011.04374.x
Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Müller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res. 2012 Mar;304(2):87-113. Epub 2012 Feb 17.
2011
Ascher B, Bayerl C, Brun P, Kestemont P, Rzany B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol. 2011; 10: 94-8.
Bachmann F, Erdmann R, Hartmann V, Becker-Wegerich P, Wiest L, Rzany B. Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study. J Eur Acad Dermatol Venereol. 2011; 25: 902-12.
Bachmann F, Erdmann R, Hartmann V, Rzany B. Consecutively injected fillers in the same region do not pose an increased risk for adverse reactions. J Eur Acad Dermatol Venereol. 2011; 25: 737-8.
Fluhr JW, Nast A. Maintenance therapy: acne as a chronic disease. Br J Dermatol. 2011; 164: 1181-2.
Mrowietz U, Kragballe K, Nast A, Reich K. Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting. J Eur Acad Dermatol Venereol. 2011; 25 Suppl 3: 1-13.
Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011; 303: 1-10
Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. [S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges. 2011; 9 Suppl 2: S1-104.
Nast A, Rosumeck S, Sammain A, Erdmann R, Sporbeck B, Rzany B. [S3-guidelines for the treatment of psoriasis vulgaris--methods report]. J Dtsch Dermatol Ges. 2011; 9 Suppl 2: e64-84.
Nast A, Reytan N, Hartmann V, Pathirana D, Bachmann F, Erdmann R, Rzany B. Efficacy and durability of two hyaluronic Acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study. Dermatol Surg. 2011; 37: 768-75.
Rosumeck S, Sporbeck B, Rzany B, Nast A. Offenlegung potenzieller Interessenkonflikte in dermatologischen Leitlinien in Deutschland - eine Analyse - Status Quo und Quo Vadis. J Dtsch Dermatol Ges. 2011;9:297-304.
Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther. 2011; 13: 107-12
Schofer H, Bruns R, Effendy I, Hartmann M, Jappe U, Plettenberg A, Reimann H, Seifert H, Shah P, Sunderkotter C, Weberschock T, Wichelhaus TA, Nast A. Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes. J Dtsch Dermatol Ges. 2011; 9: 953-67
2010
Krezdorn N, Hartmann V, Bachmann F, Nast A, Rzany B. Ästhetische Dermatologie für Studierende: gute Akzeptanz eines neuen freiwilligen Seminars. J Dtsch Dermatol Ges. 2010;8:281-3.
Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, et al. S2k-Leitlinie zur Therapie der Akne. J Dtsch Dermatol Ges. 2010;8 Suppl 2:s1-59.
Pathirana D, Nast A, Ormerod A, Reytan N, Saiag P, Smith C, Spuls P, Rzany B. On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges. J Eur Acad Dermatol Venereol. 2010;24:1458-67.
Rzany B, Ascher B, Monheit G. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol. 2010;24 Suppl 1:1-14.
Rzany B, Hilton S, Prager W, Hartmann V, Brandl G, Fischer TC et al. Expert guideline on the use of porcine collagen in aesthetic medicine. J Dtsch Dermatol Ges. 2010;8:210-7.
Sperling B, Bachmann F, Hartmann V, Erdmann R, Wiest L, Rzany B. The current state of treatment of adverse reactions to injectable fillers. Dermatol Surg. 2010;36 Suppl 3:1895-904.
Spuls PI, Nast A. Evaluation of and perspectives on guidelines: what is important? J Invest Dermatol. 2010;130:2348-9.
2009
Ascher B, Rzany B, Grover R. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crows Feet: Double-Blind, Placebo-Controlled, Dose-Ranging Study. Derm Surg 2009;35:1–9.
Hartmann V, Bachmann F, Plaschke M, Gottermeier T, Nast A, Rzany B. Handaugmentation mit stabilisierter Hyaluronsäure. J Dtsch Dermatol Ges. 2009;8(1):41-4.
Nast A, Spuls P, Ormerod A, Reytan N, Saiag P, Smith C, Rzany B. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 2009;23(7):782-7.
Nast A, Erdmann R, Hofelich V, Reytan N, Orawa H, Sterry W, Rzany B. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines. Archives of Dermatological Research. 2009;301(8):553-9.
Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R et al. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia. Vaccine. 2009;27(34):4551-9.
Pathirana D, Ormerod A D, Saiag P, Smith C, Spuls PI, Nast et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. Journal of the European Academy of Dermatology & Venereology. 2009;23 Suppl 2:1-70.
Roßner F, Roßner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: eight year results from the Injectable Filler Safety-Study (IFS-Study). J Cosmet Dermatol. 2009;8(1):14-8.
Roßner M, Roßner F, Bachmann F, Wiest L, Rzany B. Increased risk of severe adverse reactions towards an injectable filler composed of a fixed combination of methacrylate particles and hyaluronic acid (Dermalive®). Derm Surgery 2009;35 Suppl 1:367-74.
2008
Bachmann F, Rzany B. Ästhetische Medizin des Mannes: Anwendung von injizierbaren Hyalronsäurepräparaten zur Falten- und Volumenaugmentation. Kosmet Medizin 2008;29:66-74.
Hartmann V, Erdmann R, Plaschke M, Rzany B. Fortbildung Ästhetische Medizin: Hospitationskurs am anatomischen Präparat zur Augmentation des Handrückens mit injizierbaren Hyaluronsäurepräparaten. J Dtsch Dermatol Ges. 2008;6(9):751-3.
Heinz BC, Ladhoff U, Kahl Ch, Rzany B, von Mallek D. Vorkommnismeldungen zu injizierbaren Füllmaterialien. Auswertung des Medizinprodukte-Beobachtungs- und -Meldesystems in Deutschland. Bundesgesundheitsblatt Gesund-heitsforschung Gesundheitsschutz. 2008;51(7):787-92.
Lüdert T, Nast A, Zielke H, Sterry W, Rzany B. E-learning in the dermatological education at the Charité: evaluation of the last three years. J Dtsch Dermatol Ges. 2008;6(6):467-72.
Nast A, Rzany B. Leitlinien erstellen ist kein Nullsummenspiel. ÄP Dermatologie-Allergologie. 2008;1:28-32.
Nast A, Reytan N, Rosumeck S, Erdmann R, Rzany B. Low prescription rate for systemic treatments in the management of severe psoria sis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol. 2008;22(11):1337-42.
Pickett A, Dodd S, Rzany B. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications. J Cosmet Laser Ther. 2008 May 23:1-3.
Reytan N, Rzany B. Porcine Filler for Facial Lipoatrophy associated with human immunodeficiency virus treatment. J Drugs Dermatol. 2008 Sept;7(9): 884-6.
Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg. 2008 Mar;34(3):326-35.